CLASS II Drug recall · Reported 17 Oct 2012 · FDA Enforcement Report
Moexipril HCl Tablets 7.5mg, 100 tabs recalled by Paddock Laboratories
Paddock Laboratories is recalling Moexipril HCl Tablets 7.5mg, 100 tabs, distributed nationwide in the US. The recall was initiated on 3 Oct 2012 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-007-2013
- FDA event ID
- 63354
- Recalling firm
- Paddock Laboratories, Minneapolis, MN
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 3 Oct 2012
- FDA classified
- 9 Oct 2012
- Reported
- 17 Oct 2012
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
Timeline
| 3 Oct 2012 | Recall initiated by company | |
| 9 Oct 2012 | Classified by FDA | +6 days |
| 17 Oct 2012 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01 ,
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.
Which lots are affected?
2012028142 exp. 1/2014
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Paddock Laboratories
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Evamist (estradiol transdermal spray), 1.53mg estradiol/spray recalledEvamist | Paddock Laboratories | Packaging Defects | Nationwide |
| Drug | CLASS II | Perrigo, Clindamycin Palmitate Hydrochloride recalled | Paddock Laboratories | Particulate Matter | Nationwide |
Other Moexipril recalls
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Moexipril Hydrochloride and Hydrocholorothiazide Tablets recalled | Teva Pharmaceuticals USA | Potency & Assay | Nationwide |